YLR235C Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YLR235C antibody; Putative uncharacterized protein YLR235C antibody
Target Names
YLR235C
Uniprot No.

Q&A

What is the optimal method for validating YLR235C antibody specificity in yeast cells?

Validating antibody specificity is crucial for meaningful experimental outcomes. The gold standard approach combines multiple validation methods:

  • Western blot analysis comparing wild-type yeast with YLR235C deletion mutants to confirm absence of signal in knockout strains

  • Immunoprecipitation followed by mass spectrometry to identify binding partners

  • Immunofluorescence microscopy comparing localization patterns with GFP-tagged YLR235C

  • Preabsorption controls with purified YLR235C protein to demonstrate signal reduction

When conducting validation experiments, it's essential to include both positive and negative controls. For example, when screening yeast deletion libraries, include strains with known interactions as demonstrated in studies of retrotransposon mobilization . Cross-reactivity testing with closely related yeast proteins can further confirm specificity before proceeding with more complex experiments.

How does the cellular localization of YLR235C protein affect antibody selection and experimental design?

YLR235C protein's subcellular localization significantly impacts antibody selection strategy and experimental design considerations:

  • Nuclear localization requires antibodies capable of nuclear penetration, potentially necessitating fixation protocols that maintain nuclear membrane permeability

  • If associated with vesicular trafficking pathways, membrane-specific antibody formulations may yield better results

  • For proteins with dynamic localizations, consider using multiple antibodies targeting different epitopes to capture various conformational states

Similar to approaches used in studying nuclear pore components and vesicular processing complexes identified in yeast retroelement screens , research with YLR235C antibodies must account for potential protein relocalization during different cellular processes. Nuclear transport mechanisms may regulate protein availability, potentially affecting antibody binding kinetics in different cellular compartments.

What are the recommended storage conditions for maintaining YLR235C antibody stability and activity?

Maintaining antibody stability significantly impacts experimental reproducibility. For YLR235C antibodies, follow these evidence-based storage protocols:

  • Store concentrated stock (1 mg/ml) in small aliquots (20-50 μl) at -80°C to minimize freeze-thaw cycles

  • Working dilutions can be stored at 4°C with 0.02% sodium azide for up to 2 weeks

  • For long-term storage beyond 6 months, lyophilization may be preferable to frozen storage

  • Monitor stability using activity assays rather than simply checking for precipitation

Researchers working with complex-specific antibodies have demonstrated that stability can be significantly improved by adding stabilizing agents like glycerol (final concentration 30-50%) or specific buffer formulations . When storing fusion protein-generated antibodies, particular attention should be paid to preventing degradation of the complex-specific epitopes that may be more vulnerable to denaturation.

How can YLR235C antibodies be used to investigate protein complex formation in cellular stress responses?

YLR235C antibodies can provide valuable insights into dynamic protein interactions during stress responses through these methodological approaches:

  • Sequential immunoprecipitation to isolate YLR235C-containing complexes before and after stress induction

  • Proximity ligation assays to visualize in situ protein-protein interactions

  • ChIP-seq to map genomic binding sites when YLR235C functions in transcriptional regulation

  • Fluorescence resonance energy transfer (FRET) analysis with labeled antibody fragments

Recent advances in complex-specific monoclonal antibody generation demonstrate the potential for directly measuring protein complex formation in live cells . By creating fusion proteins based on YLR235C and its interaction partners, researchers can generate complex-specific antibodies that selectively recognize the assembled complex rather than individual components. This approach has successfully measured ratios of freestanding proteins to their combined complexes in immune cells , providing a model for similar studies in yeast systems.

What strategies can overcome epitope masking issues when YLR235C forms part of multiprotein complexes?

Epitope masking frequently challenges researchers working with multiprotein complexes. Implement these methodological solutions:

  • Generate antibody panels targeting different epitopes distributed across the YLR235C protein

  • Employ mild detergents or salt concentrations to partially disrupt protein-protein interactions without denaturing target proteins

  • Use peptide-specific antibodies targeting regions known to remain accessible within complexes

  • Consider native vs. denaturing conditions in immunoprecipitation protocols

When designing antibodies against YLR235C, researchers can draw from strategies used in viral antibody engineering. For example, computational approaches that identify key amino-acid substitutions can help design antibodies with improved binding properties, similar to the GUIDE team's approach for SARS-CoV-2 antibodies . By virtually assessing binding capabilities across multiple protein conformations, researchers can select antibody candidates most likely to recognize YLR235C in various complex configurations.

How can machine learning approaches enhance YLR235C antibody design and selection?

Machine learning integration has revolutionized antibody engineering, offering these methodological advantages for YLR235C research:

  • Structural prediction models can identify optimal epitopes for antibody recognition

  • Binding affinity algorithms can prescreen antibody candidates, reducing wet-lab validation requirements

  • Molecular dynamics simulations can predict antibody performance across different experimental conditions

  • Deep learning frameworks can identify subtle patterns in antibody-antigen interactions

Recent work by Lawrence Livermore National Laboratory demonstrates how computational redesign can recover antibody functionality through targeted mutations . By applying similar approaches to YLR235C antibodies, researchers can optimize binding properties without extensive trial-and-error experimentation. Their work used supercomputing capabilities to perform computational redesign of antibodies from a vast theoretical design space of over 10^17 possibilities down to just 376 candidates for laboratory evaluation , presenting an efficient model for yeast protein antibody optimization.

What controls are essential when using YLR235C antibodies in co-immunoprecipitation experiments?

Rigorous controls are critical for meaningful co-immunoprecipitation results. Implement this comprehensive control panel:

Control TypeImplementationPurposeAnalysis Method
Negative controlPre-immune serum or isotype control antibodyIdentifies non-specific bindingCompare banding patterns to experimental sample
Knockout/knockdownYLR235C deletion strainConfirms antibody specificityVerify absence of target protein band
Competing peptidePre-incubation with YLR235C peptideValidates epitope specificityObserve signal reduction
Input controlSample before immunoprecipitationConfirms presence of target proteinVerify relative enrichment after IP
Reverse IPAntibody against suspected interactorConfirms bidirectional interactionDetect YLR235C in precipitate

When designing co-IP experiments, consider that YLR235C may participate in different protein complexes depending on cellular conditions. The approach used by Sanford Burnham Prebys and Eli Lilly researchers for studying BTLA-HVEM protein complexes provides a model for investigating YLR235C interactions. By creating fusion proteins that stabilize normally transient interactions, researchers can overcome limitations of traditional co-IP methods.

How should experimental conditions be optimized when using YLR235C antibodies for chromatin immunoprecipitation (ChIP)?

ChIP protocol optimization requires systematic adjustment of multiple parameters to maximize signal-to-noise ratio:

  • Fixation conditions: Test formaldehyde concentrations (0.1-1%) and incubation times (5-20 minutes) to preserve protein-DNA interactions without overfixing

  • Sonication parameters: Optimize energy levels and cycle numbers to generate 200-500bp DNA fragments

  • Antibody concentration: Titrate antibody amounts to determine minimum concentration for maximum target enrichment

  • Washing stringency: Balance between removing non-specific interactions and preserving specific binding

An adaption of methods used in screening yeast deletion libraries can be valuable for ChIP optimization . The studies of retroelement activity identified clusters of genes encoding RNA processing proteins and DNA maintenance factors, suggesting that YLR235C antibody ChIP protocols may need to account for interactions with chromatin remodeling complexes and transcript elongation machinery.

What are the recommended approaches for multiplexing YLR235C antibodies with other detection methods?

Multiplexed detection strategies enhance data richness while conserving sample material. Implement these methodological approaches:

  • Fluorophore selection: Choose spectrally distinct fluorophores for simultaneous detection of multiple targets

  • Sequential immunodetection: Strip and reprobe membranes with different antibodies

  • Dual-color Western blotting: Utilize secondary antibodies with different fluorescent tags

  • Mass cytometry: Label antibodies with different metal isotopes for high-dimensional analysis

When designing multiplexed experiments, consider potential cross-reactivity between antibodies and implement appropriate blocking strategies. The fusion protein approach used by researchers for generating complex-specific monoclonal antibodies can be adapted for multiplexed detection of YLR235C in different protein complexes, allowing simultaneous visualization of different functional states.

How can researchers differentiate between specific and non-specific signals when using YLR235C antibodies in complex biological samples?

Signal validation requires systematic analytical approaches:

  • Signal depletion test: Pre-absorb antibody with purified YLR235C protein and observe signal reduction

  • Multiple antibody validation: Use antibodies targeting different epitopes and compare signal patterns

  • Genetic validation: Compare signals between wild-type and YLR235C deletion strains

  • Dose-response analysis: Evaluate signal linearity with increasing sample concentrations

When interpreting signals from YLR235C antibodies, consider potential cross-reactivity with structurally similar proteins. The experience from researchers studying protein complexes demonstrates that direct measurement on live cells using complex-specific monoclonal antibodies can provide higher specificity than conventional approaches . This approach may be particularly valuable when distinguishing between free YLR235C and its complex-bound forms.

What are the most common technical pitfalls when working with YLR235C antibodies and how can they be addressed?

Anticipate and mitigate these common technical challenges:

ChallengeCauseSolutionValidation Method
Loss of signal over timeAntibody degradationAdd protease inhibitors, store properlyRegular testing against standard samples
High backgroundNon-specific bindingOptimize blocking, increase washing stringencyInclude negative controls in each experiment
Inconsistent resultsBatch variationPurchase larger lots, validate each batchSide-by-side testing of old and new batches
False negativesEpitope maskingUse multiple antibodies targeting different regionsCompare detection across various methods
Cross-reactivityStructural similarity to other proteinsValidate with knockout controls, affinity purificationPre-absorption tests with related proteins

When addressing epitope masking issues, consider adopting approaches similar to those used for redesigning antibodies against viral escape variants . By identifying key amino acid substitutions that can restore binding capability, researchers can develop antibodies that maintain recognition even when YLR235C undergoes conformational changes or forms complexes with other proteins.

How should researchers analyze contradictory results from different YLR235C antibody-based experiments?

Resolving experimental contradictions requires systematic investigation:

  • Epitope mapping: Determine if different antibodies recognize distinct regions of YLR235C

  • Validation in multiple systems: Compare results across different strains, growth conditions, and detection platforms

  • Method-specific artifacts: Assess whether contradictions correlate with specific experimental approaches

  • Biological variability: Consider whether contradictions reflect actual biological heterogeneity

Researchers investigating retrotransposon mobilization discovered that nuclear pore components and DNA maintenance factors significantly affected experimental outcomes . Similarly, YLR235C antibody experiments may yield contradictory results depending on nuclear transport mechanisms or interactions with replication machinery. Analyzing these patterns can transform apparent contradictions into insights about YLR235C function.

How can engineered YLR235C antibody variants improve detection of post-translational modifications?

Antibody engineering offers promising approaches for detecting modified YLR235C forms:

  • Phospho-specific antibodies: Engineer antibodies recognizing specific phosphorylated residues

  • Modification-state dependent antibodies: Develop antibodies that differentially recognize modified vs. unmodified forms

  • Proximity-based detection: Create split-antibody systems that generate signal only when modifications bring specific domains together

  • Conformation-specific antibodies: Design antibodies that detect structural changes induced by modifications

The computational redesign approach used for viral antibodies provides a model for engineering YLR235C antibodies with enhanced specificity . By leveraging molecular dynamics simulations and machine learning algorithms, researchers can identify optimal antibody configurations for detecting specific post-translational modifications, similar to how researchers identified key amino acid substitutions to restore antibody potency against viral variants.

What emerging technologies will advance YLR235C antibody applications in single-cell analysis?

Single-cell methods are transforming our understanding of cellular heterogeneity. These emerging technologies will enhance YLR235C antibody applications:

  • Single-cell protein sequencing: Antibody-based capture of YLR235C from individual cells

  • In situ antibody sequencing: Direct visualization of multiple epitopes within intact cells

  • Spatial proteomics: Mapping YLR235C localization patterns across tissue sections at subcellular resolution

  • Antibody-based single-cell sorting: Isolating specific cellular populations based on YLR235C expression patterns

Recent advances in generating monoclonal antibodies for protein complexes demonstrate how fusion protein approaches can overcome limitations in traditional antibody production methods . Adapting these methods for single-cell applications could allow researchers to track YLR235C complex formation at unprecedented resolution, providing new insights into yeast cellular heterogeneity and protein function.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.